More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

First assessment from an RSV vaccine study in immunocompromised adults show ABRYSVO was well-tolerated and generated strong neutralizing responses after a single dose in adults ≥ 18 years of age These ...

-- Delivers Robust Earnings Performance, Successfully Navigating a Dynamic Environment -- Made Significant Progress Strengthening the R&D Organization -- On Track to Exceed Net Cost Savings Targets ...

The MarketWatch News Department was not involved in the creation of this content. -- Strengthened Commercial Execution Driving Topline Growth -- Continued Progress Across R&D Pipeline -- Expanded ...

Pfizer Inc. and Tris Pharma Inc. will pay the state of Texas $41.5 million to settle claims that it allegedly provided ...

The Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The treatment ...

Pfizer signed a deal with the White House to help Americans pay lower prices for prescription drugs. This agreement removes the uncertainty hanging over Pfizer's head related to the Trump ...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that the company is launching the process to identify a successor for Dr. Mikael Dolsten, Pfizer’s Chief Scientific Officer and ...

Pfizer and manufacturer Tris Pharma have agreed to hand over $41.5 million to lay to rest a 2023 lawsuit accusing the ...